MILLER RICHARD A MD

CIK 00010318473 companiesBURLINGAME, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001031847

Recent Transactions

50 trades

Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2025-12-04+1,000,000→ 1,000,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2025-05-07$3.50/sh+559,073→ 1,136,707 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Warrant (Right to Buy)
2025-05-07−559,073→ 0 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2024-12-20+750,000→ 750,000 total
Gift
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2024-05-10−302,016→ 1,188,103 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2024-05-06$1.73/sh+577,634→ 577,634 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Warrant (Right to Buy)
2024-05-06+559,073→ 559,073 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-12-06+500,000→ 500,000 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2023-06-12+25,000→ 25,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-03-31+800,000→ 800,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-12-14$0.78/sh+10,000→ 1,490,119 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2022-12-14+25,000→ 25,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-12-13$0.74/sh+50,000→ 1,480,119 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-09-28$0.76/sh+25,000→ 1,394,405 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-09-20$0.81/sh+5,000→ 1,369,405 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-09-20$0.82/sh+2,700→ 1,364,405 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-09-20$0.81/sh+12,300→ 1,361,705 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2022-08-11+320,000→ 320,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-06-27$1.00/sh+5,000→ 1,349,405 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-06-24$1.03/sh+5,000→ 1,344,405 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2022-06-10+25,000→ 25,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-06-06$1.01/sh+890→ 1,339,405 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-06-02$0.97/sh+170→ 1,338,515 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-06-02$0.98/sh+4,830→ 1,338,345 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-03-31$1.64/sh+15,000→ 1,333,515 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2022-03-24+25,000→ 25,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-03-17$1.59/sh+5,000→ 1,318,515 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-03-15$1.47/sh+25,000→ 1,313,515 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2021-09-09+320,000→ 320,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2021-08-20$1.93/sh+10,000→ 1,288,515 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2021-05-04$2.80/sh+35,714→ 35,714 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2021-02-17$3.50/sh+100,000→ 1,278,515 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2020-12-16+320,000→ 320,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2019-12-12+320,000→ 320,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2019-11-13$3.00/sh+14,736→ 1,178,515 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2019-11-12$2.90/sh+272→ 1,163,779 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-08-07$3.54/sh+2,500→ 1,163,507 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-08-06$3.58/sh+5,000→ 1,161,007 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-14$3.40/sh+11,657→ 1,156,007 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-13$3.52/sh+343→ 1,144,350 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-11$3.67/sh+6,000→ 1,144,007 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-07$3.37/sh+9,212→ 1,138,007 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-27$3.29/sh+20,000→ 1,128,795 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-20$4.40/sh+5,000→ 1,103,795 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-20$4.39/sh+5,000→ 1,108,795 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2018-12-12+250,000→ 250,000 total
Gift
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-11−10,000→ 1,098,795 total
Gift
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-11−10,000→ 1,108,795 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-06$5.99/sh+5,000→ 1,118,795 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-04$5.95/sh+1,502→ 1,113,795 total

Companies

Recent Filings

Address

C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102

BURLINGAME, CA, 94010

View on SEC.gov